Charles River was proud to contribute to the scientific program of the 2019 FOCIS Annual Meeting with 13 poster presentations covering a variety of research topics. We invite you to review and download a copy of the posters listed below.
Scientific Poster Presentations
A Translational Platform to Support and Advance Immuno-Oncology Drug Discovery | Jeroen De Groot, PhD
Analysis of Molecular and Cellular Responses Associated with Immune Checkpoint Inhibition in the MC38 Colon Carcinoma Model | David Harris, PhD
Building a Translational Pathway Using Human Myeloid Cell Assays to Enable Development of Cancer Immune Therapies | Louise Brackenbury, PhD
Building a Translational Pathway Using Pharmacodynamic Models to Enable the Development of Cancer Immune Therapies | Rhiannon Jenkinson, PhD
Deciphering the Role of the Tumor Infiltrating Lymphocytes in Anti-Angiogenic Therapy Using a Humanized PDX In Vivo Platform | Julia Schueler, PhD
Development of In Vitro Assays for the Assessment of Potential Drugs Regulating the Migration of Blood-Derived Human Monocytes or Neutrophils | Lisa Scandiuzzi, PhD
Evaluation of Different Lactobacillus Strains on the Treatment of Inflammatory Bowel Disease in a Murine Model | Rana Samadfam, PhD
Inclusion of Exploratory PD Biomarkers in First-in-human Clinical Trials Adds Value by Providing Information to Confirm the Mode of Action of a Candidate Therapeutic | Rhiannon Jenkinson, PhD
LPS-induced Neuroinflammation Assay Combination for Development of New Treatment Strategies | Gunnar Flik, PhD
Modelling Inflammatory Bowel Disease using a Translational Assay Platform | Louise Brackenbury, PhD
Profiling of 1,600 Novel Natural Product-based Compounds in Human Primary Cell-based Phenotypic Assays | Jamil Aarbiou, PhD
Th17-derived Cytokines Might be Involved in the Allergic Contact Dermatitis Induced by Poison Ivy Active Ingredient, Urushiol | Rana Samadfam, PhD
Two In Vitro Assays for Evaluating the Potency and Efficacy of Prospective Drugs in Multiple Diseases Involving Both Classically and Alternative Activated Macrophages | Sanne Demandt, PhD